By Amina Niasse NEW YORK, June 2 (Reuters) - Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo ...
Cigna (CI) is ending coverage for GLP-1 weight-loss drugs such as Eli Lilly's (LLY) Zepbound and Novo Nordisk’s (NVO) Wegovy ...
Sheridan Capital Partners ("Sheridan") today announced the completion of its investment in Tres Health, Inc. ("Tres" or the ...
Eli Lilly and Company just secured a big win as it looks to expand GLP-1 access, mending its partnership with top pharmacy ...
Cigna drop GLP coverage for employees on July 1, excluding Type 2 diabetes, amid rising cost pressures on employer health plans.
CNBC's Becky Quick reports on the latest news.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results